Livewire Markets on MSN4h
ResMed's latest earnings are "super impressive", says this fund manager
Although RMD has re-rated from its share price low of around $21.50 in October 2023, it has only just surpassed its all-time ...
ResMed's Moat Is Underpinned by Switching Costs and Intangible Brand Assets
Due to its significant market share and high gross margins in a structurally growing industry, ResMed has posted an average return on invested capital, or ROIC, of 20% over the last decade. We ...
This 10-15-minute trick will get you back to sleep if you’re tossing and turning
He echoed Lu’s advice for getting up and getting out when sleep is scarce: “When you’ve been tossing and turning, try moving to the floor in a different, cooler room. Use a yoga mat or soft surface, ...
FDA approves medication for sleep apnea
The U.S. Food and Drug Administration calls Zepbound the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea and obesity. The approval supports evidence ...
ResMed reports Q2 EPS $2.43, consensus $2.31
Reports Q2 revenue $1.28B, consensus $1.27B. “Our second quarter fiscal year 2025 top-line growth, margin expansion, and double-digit EPS ...
American Association of Individual Investors15h
3 Undervalued Health Care Providers & Services Stocks for Thursday, January 30
Discover the top 3 undervalued Health Care Providers & Services stocks for Thursday, January 30 based on AAII’s Stock Grades.